Latest updates for Glp-1 Peptides

Fresh curated links around GLP-1 peptides are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • GLP-1 Benefits Are Growing Fast: The Follow-Up Problem Nobody Talks About
  • GLP-1s may combat depression by multiplying a mood-boosting gut microbe
  • The Next Wave of Weight Loss Science May Come From a Peptide Inside Your Body That Mimics Ozempic

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

hrmorning.com /1 month ago

GLP-1 Benefits Are Growing Fast: The Follow-Up Problem Nobody Talks About

GLP-1 medications and hormone therapies have moved from niche to mainstream. About 19% of large employers now cover GLP-1 drugs used primarily for weight loss, according to the Kai...

Read source
fiercebiotech.com /1 month ago

GLP-1s may combat depression by multiplying a mood-boosting gut microbe

Since GLP-1 drugs like Novo Nordisk’s semaglutide and Eli Lilly’s tirzepatide took the world by storm for their potent treatment of diabetes and obesity, they have also been plague...

Read source
womansworld.com /1 month ago

The Next Wave of Weight Loss Science May Come From a Peptide Inside Your Body That Mimics Ozempic

GLP-1 alternatives are getting fresh attention after Stanford researchers identified a naturally occurring peptide called BRP that suppressed appetite in animals without the nausea...

Read source
nytimes.com /1 month ago

GLP-1 Drugs: 6 Things We’ve Learned About Their Effects

The widespread use of drugs like Ozempic is giving scientists a clearer picture than ever of their effects.

Read source
npr.org /1 month ago

GLP-1s appear to protect against cancer. Researchers are trying to figure out how

Recent studies suggest the weight loss and diabetes drugs may prevent cancer and slow its progression. While weight loss is known to curb cancer risks, GLP-1s may act on other brai...

Read source
nytimes.com /2 weeks ago

Could GLP-1 Drugs Help You Live Longer?

Experts are intrigued by the theory. Here’s what early research suggests.

Read source
scientificamerican.com /3 weeks ago

Can GLP-1s boost testosterone levels?

Preliminary study finds that testosterone levels increase or stabilize in people taking GLP-1 medications

Read source
healio.com /4 weeks ago

GLP-1s may cut liver complication risk in MASLD, type 2 diabetes

Use of GLP-1s was associated with significantly reduced risk for hepatic complications among patients with metabolic dysfunction-associated steatotic liver disease and type 2 diabe...

Read source
refractor.io /1 month ago

Brain-cell breakthrough supercharges GLP-1 weight loss and prevents plateaus

Scientists have identified a new way to supercharge the GLP-1 receptor agonist semaglutide, opening the door to boosting the drug's weight-loss power and helping long-term users pu...

Read source
drugs.com /1 month ago

GLP-1 Meds May Help Slow the Spread of Certain Obesity-Related Cancers

WEDNESDAY, May 27, 2026 — A new study suggests GLP-1 medications may slow the spread of certain obesity-related cancers. "GLP-1 receptor agonists have never been just glucose-lower...

Read source
healio.com /3 weeks ago

GLP-1 use confers benefits in obesity, autoimmune disease

NEW ORLEANS — Individuals with obesity and autoimmune diseases who use a GLP-1 receptor agonist may have lower risk for mortality, fewer cardiovascular and thrombotic events and lo...

Read source
mindbodygreen.com /1 month ago

Analysis Of 43K+ Adults Shows What GLP-1s Are Actually Doing For Blood Pressure

These drugs are quickly proving to go way beyond weight loss.

Read source
wkbn.com /3 weeks ago

Which GLP-1 works best? New meta-study puts them head-to-head

The study compared three types of the medication: tirzepatide (better known under the brand names Zepbound and Mounjaro), semaglutide (sold as Wegovy and Ozempic), and liraglutide...

Read source
psychologytoday.com /1 month ago

Do GLP-1's Change Your Personality?

GLP-1's decrease your appetite for food but perhaps much more as well. Here's what those considering a prescription should understand.

Read source
healio.com /2 weeks ago

GLP-1s may lower risk for knee replacement in osteoarthritis

GLP-1 receptor agonists, particularly new generation agents such as semaglutide and tirzepatide, may significantly reduce the risk for arthroplasty in patients with knee osteoarthr...

Read source
huffpost.com /1 month ago

GLP-1 Users May Experience A Surprising Life-Saving Benefit That Has Nothing To Do With Weight Loss

A new study found that some cancer patients who took GLP-1 drugs saw some remission — especially if they had breast cancer.

Read source
mainstreetvegan.com /1 month ago

How Vegan Eating Naturally Supports Your GLP-1 Hormone by Anna Pelzer, VLCE

Posted May 26, 2026 GLP-1 has become one of the most talked-about hormones in nutrition and weight management, and for good reason. This naturally occurring hormone helps regulate...

Read source
ktla.com /3 weeks ago

Which GLP-1 works best? New meta-study puts them head-to-head

The study compared three types of the medication: tirzepatide (better known under the brand names Zepbound and Mounjaro), semaglutide (sold as Wegovy and Ozempic), and liraglutide...

Read source
bioengineer.org /4 weeks ago

New Study Finds GLP-1 Medications May Reduce Risk of Violent Behavior

In recent years, glucagon-like peptide-1 (GLP-1) receptor agonists have emerged primarily as breakthrough medications targeting metabolic disorders such as type 2 diabetes and obes...

Read source
sciencedaily.com /1 month ago

New GLP-1 diabetes pill delivers major weight loss and blood sugar control

A new oral GLP-1 medication helped people with type 2 diabetes dramatically improve blood sugar control and lose weight in a major clinical trial. The results suggest that highly e...

Read source
fiercebiotech.com /1 month ago

Lilly pens $1.2B deal for Hanmi’s GLP-2 drug being aimed at short bowel syndrome

Eli Lilly has expanded its glucagon-like peptide portfolio in an intriguing direction by licensing a phase 2-stage GLP-2 agonist from Hanmi Pharm.

Read source
fourstateshomepage.com /1 month ago

Do GLP-1 pills work as well as injections? Here's what studies show about weight loss, side effects

GLP-1 drugs are now friendlier to needle-phobes. But do the pills still work?

Read source
foxnews.com /1 month ago

‘Wild West’ peptide craze surges beyond GLP-1s as FDA faces pressure to ease access

The peptide market is surging alongside GLP-1 demand, creating tension between compounding pharmacies and commercial drug companies over patient access.

Read source
scientificamerican.com /1 month ago

Why GLP-1 drugs might reduce cancer risk

A new wave of research links GLP-1 drugs to reduced cancer spread and better survival, and the mechanism may go beyond just weight loss

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Glp-1 Peptides

feeds.foxnews.com

Recent coverage from public sources
Public source

rss.sciam.com

Recent coverage from public sources
Public source

bioengineer.org

Recent coverage from public sources
Public source

feeds.feedburner.com

Recent coverage from public sources
Public source

feeds.npr.org

Recent coverage from public sources
Public source

ktla.com

Recent coverage from public sources
Public source